Delivery Order HT942525D0009-HT942626FE011
Award Date 2/6/26
Potential Completion Date 4/24/26
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $110.5 million firm fixed-price delivery order to Mapp Biopharmaceutical, Inc., a San Diego-based biotechnology company specializing in antibody-based therapeutics and medical countermeasures. The delivery order, awarded on June 6, 2025, with completion scheduled for December 4, 2025, calls for the supply of monoclonal antibodies and viral recombinant antigens. No set-aside designation was used in this award. This delivery order is issued under Mapp's...
- The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $28.87 million cost-plus-fixed-fee definitive contract to Mapp Biopharmaceutical, Inc. on June 27, 2016, for an Expanded Access Protocol supporting ZMapp, an investigational monoclonal antibody therapeutic. The contract, with performance through December 31, 2027, at Mapp's San Diego, California facility, includes receipt of government-furnished property from related Medical Countermeasures Against Pathogens...
- The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a cost-plus-fixed-fee contract valued at $299.0 million to Mapp Biopharmaceutical, Inc. on September 28, 2022, for the development of MBP091, an immunotherapy candidate for treating Marburg virus infection. This definitive contract, with an ultimate completion date of July 31, 2036, originated from a Biomedical Advanced Research and Development Authority (BARDA) broad agency announcement soliciting proposals for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,270.30 on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, identified as COMIRNATY 2024-25 (12 years and up) at 0.3 milliliters, represents a single-dose vaccine supply for military healthcare operations. The contract was competitively awarded with no set-aside provisions and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Moderna COVID-19 vaccine (6M-11Y formulation) in 0.25mL doses, with a ceiling value of $1,302.54. This is a firm fixed-price delivery order with no set-aside designation, issued competitively and scheduled for completion by June 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, with a ceiling value of $2,632.00 and an ultimate completion date of December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of COMIRNATY 2025-26 vaccine (12-year-old and up formulation) in 0.3ml syringes, with a ceiling value of $1,221.90. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is scheduled for completion by December 29, 2025, with performance to take place at AmerisourceBergen's corporate office in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of M-M-R II vaccine vials valued at $18,132.54. This firm fixed-price delivery order, with a completion deadline of September 2, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability...
- This is a $30,559,760.00 cost-plus-fixed-fee delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for the development of the MAPP biopharmaceutical Viral Hemorrhagic Fever (VHF) Medical Countermeasure (MCM) platform. This work is being performed under the Centers for Innovation in...